Hepatitis B Treatment Response to TDF in 3TC-Experienced Perinatally HIV-Infected Adolescents
Background: HIV and Hepatitis B (HBV) coinfection is associated with high risk of progression to chronic liver diseases. Loss of the hepatitis B surface (HBsAg) and envelop (HBeAg) antigens are the ultimate goals of treatment. This study aims to determine the incidence rate of seroconversion and kinetics of HBV in perinatally HBV/HIV coinfected adolescents treating…